CRISPR Stock Probability of Future Stock Price Finishing Over 100.0

CRSP
 Stock
  

USD 68.24  1.28  1.91%   

CRISPR Therapeutics' future price is the expected price of CRISPR Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of CRISPR Therapeutics AG performance during a given time horizon utilizing its historical volatility. As of 27th of June 2022, Price to Book Value is likely to grow to 3.01. Also, Price to Earnings Ratio is likely to grow to 16.45.
  
Refresh
CRISPR Therapeutics' implied volatility is one of the determining factors in the pricing options written on CRISPR Therapeutics AG. Implied volatility approximates the future value of CRISPR Therapeutics based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in CRISPR Therapeutics AG over a specific time period. For example, 2022-07-01 CALL at $68.0 is a CALL option contract on CRISPR Therapeutics' common stock with a strick price of 68.0 expiring on 2022-07-01. The contract was last traded on 2022-06-24 at 15:50:29 for $2.02 and, as of today, has 5 days remaining before the expiration. The option is currently trading at a bid price of $0.95, and an ask price of $3.6. The implied volatility as of the 27th of June is 67.0058. View All CRISPR options

Closest to current price CRISPR long CALL Option Payoff at Expiration

Continue to CRISPR Therapeutics Backtesting, CRISPR Therapeutics Valuation, CRISPR Therapeutics Correlation, CRISPR Therapeutics Hype Analysis, CRISPR Therapeutics Volatility, CRISPR Therapeutics History as well as CRISPR Therapeutics Performance. Please specify CRISPR Therapeutics time horizon, a valid symbol (red box) and a target price (blue box) you would like CRISPR Therapeutics odds to be computed.
Apply Odds

CRISPR Therapeutics Target Price Odds to finish over 100.0

The tendency of CRISPR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 100.00  or more in 90 days
 68.24 90 days 100.00  near 1
Based on a normal probability distribution, the odds of CRISPR Therapeutics to move over $ 100.00  or more in 90 days from now is near 1 (This CRISPR Therapeutics AG probability density function shows the probability of CRISPR Stock to fall within a particular range of prices over 90 days) . Probability of CRISPR Therapeutics price to stay between its current price of $ 68.24  and $ 100.00  at the end of the 90-day period is about 9.35 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.69 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CRISPR Therapeutics will likely underperform. Additionally The company has an alpha of 0.3794, implying that it can generate a 0.38 percent excess return over DOW after adjusting for the inherited market risk (beta).
 CRISPR Therapeutics Price Density 
      Price 

Predictive Modules for CRISPR Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CRISPR Therapeutics. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of CRISPR Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of CRISPR Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
61.1666.6672.16
Details
Intrinsic
Valuation
LowReal ValueHigh
60.2689.3294.82
Details
Naive
Forecast
LowNext ValueHigh
59.1964.6970.19
Details
16 Analysts
Consensus
LowTarget PriceHigh
100.00160.69220.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CRISPR Therapeutics. Your research has to be compared to or analyzed against CRISPR Therapeutics' peers to derive any actionable benefits. When done correctly, CRISPR Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in CRISPR Therapeutics.

CRISPR Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. CRISPR Therapeutics is not an exception. The market had few large corrections towards the CRISPR Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CRISPR Therapeutics AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CRISPR Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.38
β
Beta against DOW1.69
σ
Overall volatility
6.89
Ir
Information ratio 0.05

CRISPR Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CRISPR Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CRISPR Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
CRISPR Therapeutics has very high historical volatility over the last 90 days
About 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.benzinga.com: Statistics on Global CRISPR Genome Editing Market Size Share to Surpass USD 15.84 Billion by 2028, Exhi - Benzinga

CRISPR Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CRISPR Stock often depends not only on the future outlook of the current and potential CRISPR Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CRISPR Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out13.21%
Short Percent Of Float15.30%
Float Shares76.32M
Average Daily Volume Last 10 Day3.73M
Shares Short Prior Month10.14M
Average Daily Volume In Three Month1.71M
Date Short Interest31st of May 2022

CRISPR Therapeutics Technical Analysis

CRISPR Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. CRISPR Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CRISPR Therapeutics AG. In general, you should focus on analyzing CRISPR Stock price patterns and their correlations with different microeconomic environments and drivers.

CRISPR Therapeutics Predictive Forecast Models

CRISPR Therapeutics time-series forecasting models is one of many CRISPR Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CRISPR Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about CRISPR Therapeutics

Checking the ongoing alerts about CRISPR Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CRISPR Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

CRISPR Therapeutics Alerts

CRISPR Therapeutics Alerts and Suggestions

CRISPR Therapeutics has very high historical volatility over the last 90 days
About 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.benzinga.com: Statistics on Global CRISPR Genome Editing Market Size Share to Surpass USD 15.84 Billion by 2028, Exhi - Benzinga
Continue to CRISPR Therapeutics Backtesting, CRISPR Therapeutics Valuation, CRISPR Therapeutics Correlation, CRISPR Therapeutics Hype Analysis, CRISPR Therapeutics Volatility, CRISPR Therapeutics History as well as CRISPR Therapeutics Performance. Note that the CRISPR Therapeutics information on this page should be used as a complementary analysis to other CRISPR Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for CRISPR Stock analysis

When running CRISPR Therapeutics price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is CRISPR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CRISPR Therapeutics. If investors know CRISPR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CRISPR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.74
Return On Assets
0.0855
Return On Equity
0.15
The market value of CRISPR Therapeutics is measured differently than its book value, which is the value of CRISPR that is recorded on the company's balance sheet. Investors also form their own opinion of CRISPR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CRISPR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CRISPR Therapeutics' market value can be influenced by many factors that don't directly affect CRISPR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CRISPR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine CRISPR Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CRISPR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.